Radiomics Multifactorial Biomarker for Pulmonary Nodules — RMBPN  

Neoplasms Clinical Trial

Official title: Radiomics and Clinical Variables Can Differentiate Malignant Nodules and Detect Invasive Adenocarcinoma in Pulmonary Nodules: a Multi-center Study

Status Completed

Clinical Trial Summary

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

Clinical Trial Description

With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that a large number of patients have undergone surgery.

Although a number of radiological studies have been used morphological signs so-called semantic features to make a differential diagnosis, it is still hard to apply by clinician because pulmonary nodules especially ground-glass nodules and small size nodules have atypical radiology signs and have strong subjectivity from different observers. Recently, CT-based radiomics, extracting the quantitative high-throughput features from medical images and facilitating clinical decision-making system, showed a good performance to predict diagnosis and prognosis of diverse cancer.

Therefore, the proposed project aims to develop and validate radiomics models based on CT images to identify malignant nodules and then to discriminate the different types of lung adenocarcinoma in patients with pulmonary nodules. ;

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• Lung Diseases
• Lung Neoplasms
• Multiple Pulmonary Nodules
• Neoplasms
• Pathology

• NCT number: NCT03872362
• Study type: Observational
• Source: Maastricht University
• Status: Completed
• Start date: July 11, 2018
• Completion date: February 1, 2019